Table 3 Detailed blood/serum/plasma work-up
From: Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
Blood/serum/plasma markers | |
|---|---|
Complete blood count | |
Hemoglobin, hematocrit, mean corpuscular value, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelets, white blood cells | |
Liver tests | |
Albumin, bilirubin, ALT, AST, ALP, γGT, PT(INR), high sensitive C-reactive protein | |
Iron studies | |
Iron, transferrin saturation, total iron binding capacity, ferritin | |
Serum protein electrophoresis | |
Antitrypsin, albumin, orosomucoid, haptoglobin, immunoglobulins (IgG, IgM, IgA) | |
Minor kidney function panel | |
Sodium (Na), potassium (K), creatinine | |
Metabolic tests | |
Cholesterol, triglycerides, LDL, HDL. fasting glucose, C-peptide, HbA1c, insulin, GAD-antibody | |
Direct alcohol marker | |
Phosphatidylethanol | |
Auto-antibody screen | |
ANA, anti-LKM antibody, anti-SM antibody, anti-M antibody | |
Viral serology | |
HBsAg, anti-HBc, anti-HCV, Hep A IgM, Hep A IgG |